Director – LNP Discovery
CRISPR Therapeutics
Director – LNP Discovery
CRISPR Therapeutics
Develops gene-editing therapies using CRISPR
Job Description:
Company Overview
Since its inception over a decade ago, CRISPR Therapeutics has transformed from a research-stage company advancing programs in the field of gene editing, to a company with a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular and rare diseases. The Nobel Prize-winning CRISPR science has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Position Summary
CRISPR Therapeutics is seeking an individual with deep expertise in the RNA delivery space to lead our mRNA delivery efforts. Reporting to the Head of Translational Biology, they will oversee the development of novel LNP (lipid nanoparticle) systems for extrahepatic delivery. The successful candidate must be able to work in a fast paced and highly dynamic Biotech environment. The ideal candidate will be a leader and a great team player with excellent communication skills and an effective, inspiring management style.
Responsibilities
Minimum Qualifications
Preferred Qualifications
Competencies
Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.
Director, LNP Discovery: Base pay range of $195,000 to $215,000+ bonus, equity and benefits
The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.
CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy
Develops gene-editing therapies using CRISPR
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 to treat serious diseases, targeting conditions like sickle cell disease and cancer. Its therapies involve editing patient cells either outside the body (ex vivo) or inside the body (in vivo) to correct disease-causing genes, followed by clinical testing and potential commercialization. The company differentiates itself through a strategy of pursuing partnerships and licensing deals to fund its pipeline and accelerate development, alongside its own research and clinical programs. Its goal is to provide durable, disease-modifying treatments that address unmet medical needs for patients worldwide through a global biopharmaceutical approach.
Explore more opportunities at CRISPR Therapeutics